EBV protein BNLF2a exploits host tail-anchored protein integration machinery to inhibit TAP

Journal of Immunology

Volumn 186, Issue 6, 2011, Pages 3594-3605

  Horst, Daniëlle ^a,b   Favaloro, Vincenzo ^c,g   Vilardi, Fabio ^c   Van Leeuwen, Hans C ^b   Garstka, Malgorzata A ^b,h   Hislop, Andrew D ^d   Rabu, Catherine ^e   Kremmer, Elisabeth ^f   Rickinson, Alan B ^d   High, Stephen ^e   Dobberstein, Bernhard ^c   Ressing, Maaike E ^a,b   Wiertz, Emmanuel J H J ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

^f INSTITUTE OF EPIDEMIOLOGY   (Germany)

^g STANFORD UNIVERSITY   (United States)

^h NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; EPSTEIN BARR VIRUS PROTEIN; HLA ANTIGEN CLASS 1; PROTEIN ASNA1; PROTEIN BNLF2A; TAIL ANCHORED PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO TERMINAL SEQUENCE; ANTIGEN RECOGNITION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CYTOSOL; DOWN REGULATION; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; HYDROPHILICITY; HYDROPHOBICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROCESSING; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ARSENITE TRANSPORTING ATPASES; ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; DOWN-REGULATION; ENDOPLASMIC RETICULUM; EPSTEIN-BARR VIRUS INFECTIONS; HEK293 CELLS; HELA CELLS; HERPESVIRUS 4, HUMAN; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY; VIRAL MATRIX PROTEINS; VIRUS INTEGRATION;

EID: 79953213299     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002656     Document Type: Article

References (47)

1. Rickinson, A. B., and E. Kieff. 2001. Epstein-Barr virus. In Field's Virology, Vol. 2. D. M. Knipe, and P. M. Howley, eds. Lippincott Williams & Wilkins, Philadelphia, p. 2575-2627.
2. Kieff, E., and A. B. Rickinson. 2007. Epstein-Barr virus and its replication. In Field's Virology, 5th ed., Vol. 2. D. M. Knipe, and P. M. Howley, eds. Lippincott Williams & Wilkins, Philadelphia, p. 2603-2654.
3. + T cell immunity via concerted actions of multiple gene products. Semin. Cancer Biol. 18: 397-408.
4. Gottschalk, S., H. E. Heslop, and C. M. Roon. 2002. Treatment of Epstein-Barr virus-associated malignancies with specific T cells. Adv. Cancer Res. 84: 175-201.
5. Cresswell, P. 2000. Intracellular surveillance: controlling the assembly of MHC class I-peptide complexes. Traffic 1: 301-305.
6. Wearsch, P. A., and P. Cresswell. 2008. The quality control of MHC class I peptide loading. Curr. Opin. Cell Biol. 20: 624-631.
7. Schölz, C., and R. Tampé. 2009. The peptide-loading complex - antigen translocation and MHC class I loading. Biol. Chem. 390: 783-794.
8. Früh, K., K. Ahn, H. Djaballah, P. Sempé, P. M. van Endert, R. Tampé, P. A. Peterson, and Y. Yang. 1995. A viral inhibitor of peptide transporters for antigen presentation. Nature 375: 415-418.
9. Hill, A., P. Jugovic, I. York, G. Russ, J. Bennink, J. Yewdell, H. Ploegh, and D. Johnson. 1995. Herpes simplex virus turns off the TAP to evade host immunity. Nature 375: 411-415.
10. + T lymphocytes. Cell 77: 525-535.
11. Ahn, K., A. Gruhler, B. Galocha, T. R. Jones, E. J. Wiertz, H. L. Ploegh, P. A. Peterson, Y. Yang, and K. Früh. 1997. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity 6: 613-621. (Pubitemid 27239352)
12. Hengel, H., J. O. Koopmann, T. Flohr, W. Muranyi, E. Goulmy, G. J. Hämmerling, U. H. Koszinowski, and F. Momburg. 1997. A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. Immunity 6: 623-632. (Pubitemid 27239353)
13. Lehner, P. J., J. T. Karttunen, G. W. Wilkinson, and P. Cresswell. 1997. The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation. Proc. Natl. Acad. Sci. USA 94: 6904-6909.
14. Koppers-Lalic, D., E. A. Reits, M. E. Ressing, A. D. Lipinska, R. Abele, J. Koch, M. Marcondes Rezende, P. Admiraal, D. van Leeuwen, K. Bienkowska-Szewczyk, et al. 2005. Varicelloviruses avoid T cell recognition by UL49.5-mediated inactivation of the transporter associated with antigen processing. Proc. Natl. Acad. Sci. USA 102: 5144-5149.
15. Alzhanova, D., D. M. Edwards, E. Hammarlund, I. G. Scholz, D. Horst, M. J. Wagner, C. Upton, E. J. Wiertz, M. K. Slifka, and K. Früh. 2009. Cowpox virus inhibits the transporter associated with antigen processing to evade T cell recognition. Cell Host Microbe 6: 433-445.
16. Byun, M., M. C. Verweij, D. J. Pickup, E. J. Wiertz, T. H. Hansen, and W. M. Yokoyama. 2009. Two mechanistically distinct immune evasion proteins of cowpox virus combine to avoid antiviral CD8 T cells. Cell Host Microbe 6: 422-432.
17. + T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primates. J. Exp. Med. 204: 1863-1873.
18. Barnstable, C. J., W. F. Bodmer, G. Brown, G. Galfre, C. Milstein, A. F. Williams, and A. Ziegler. 1978. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis. Cell 14: 9-20. (Pubitemid 8340429)
19. Malissen, B., N. Rebai, A. Liabeuf, and C. Mawas. 1982. Human cytotoxic T cell structures associated with expression of cytolysis. I. Analysis at the clonal cell level of the cytolysis-inhibiting effect of 7 monoclonal antibodies. Eur. J. Immunol. 12: 739-747.
20. Hochstenbach, F., V. David, S. Watkins, and M. B. Brenner. 1992. Endoplasmic reticulum resident protein of 90 kilodaltons associates with the T- and B-cell antigen receptors and major histocompatibility complex antigens during their assembly. Proc. Natl. Acad. Sci. USA 89: 4734-4738.
21. Hargrave, P. A., G. Adamus, A. Arendt, J. H. McDowell, J. Wang, A. Szaby, D. Curtis, and R. W. Jackson. 1986. Rhodopsin's amino terminus is a principal antigenic site. Exp. Eye Res. 42: 363-373.
22. Horst, D., D. van Leeuwen, N. P. Croft, M. A. Garstka, A. D. Hislop, E. Kremmer, A. B. Rickinson, E. J. Wiertz, and M. E. Ressing. 2009. Specific targeting of the EBV lytic phase protein BNLF2a to the transporter associated with antigen processing results in impairment of HLA class I-restricted antigen presentation. J. Immunol. 182: 2313-2324.
23. Koch, J., R. Guntrum, and R. Tampé. 2006. The first N-terminal transmembrane helix of each subunit of the antigenic peptide transporter TAP is essential for independent tapasin binding. FEBS Lett. 580: 4091-4096. (Pubitemid 44037575)
24. van den Born, E., C. C. Posthuma, K. Knoops, and E. J. Snijder. 2007. An infectious recombinant equine arteritis virus expressing green fluorescent protein from its replicase gene. J. Gen. Virol. 88: 1196-1205.
25. Vellinga, J., T. G. Uil, J. de Vrij, M. J. Rabelink, L. Lindholm, and R. C. Hoeben. 2006. A system for efficient generation of adenovirus protein IX-producing helper cell lines. J. Gene Med. 8: 147-154.
26. van Lith, M., M. van Ham, A. Griekspoor, E. Tjin, D. Verwoerd, J. Calafat, H. Janssen, E. Reits, L. Pastoors, and J. Neefjes. 2001. Regulation of MHC class II antigen presentation by sorting of recycling HLA-DM/DO and class II within the multivesicular body. J. Immunol. 167: 884-892. (Pubitemid 32660844)
27. Favaloro, V., M. Spasic, B. Schwappach, and B. Dobberstein. 2008. Distinct targeting pathways for the membrane insertion of tail-anchored (TA) proteins. J. Cell Sci. 121: 1832-1840. (Pubitemid 351943376)
28. Kikkert, M., G. Hassink, M. Barel, C. Hirsch, F. J. van der Wal, and E. Wiertz. 2001. Ubiquitination is essential for human cytomegalovirus US11-mediated dislocation of MHC class I molecules from the endoplasmic reticulum to the cytosol. Biochem. J. 358: 369-377. (Pubitemid 32826353)
29. Favaloro, V., F. Vilardi, R. Schlecht, M. P. Mayer, and B. Dobberstein. 2010. Asna1/TRC40-mediated membrane insertion of tail-anchored proteins. J. Cell Sci. 123: 1522-1530.
30. van Ham, S. M., E. P. Tjin, B. F. Lillemeier, U. Grüneberg, K. E. van Meijgaarden, L. Pastoors, D. Verwoerd, A. Tulp, B. Canas, D. Rahman, et al. 1997. HLA-DO is a negative modulator of HLA-DM-mediated MHC class II peptide loading. Curr. Biol. 7: 950-957.
31. Salter, R. D., D. N. Howell, and P. Cresswell. 1985. Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids. Immunogenetics 21: 235-246. (Pubitemid 15117182)
32. Karttunen, J. T., P. J. Lehner, S. S. Gupta, E. W. Hewitt, and P. Cresswell. 2001. Distinct functions and cooperative interaction of the subunits of the transporter associated with antigen processing (TAP). Proc. Natl. Acad. Sci. USA 98: 7431-7436.
33. Carlotti, F., M. Bazuine, T. Kekarainen, J. Seppen, P. Pognonec, J. A. Maassen, and R. C. Hoeben. 2004. Lentiviral vectors efficiently transduce quiescent mature 3T3-L1 adipocytes. Mol. Ther. 9: 209-217.
34. Wiertz, E. J., T. R. Jones, L. Sun, M. Bogyo, H. J. Geuze, and H. L. Ploegh. 1996. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84: 769-779.
35. Wilson, R., A. J. Allen, J. Oliver, J. L. Brookman, S. High, and N. J. Bulleid. 1995. The translocation, folding, assembly and redox-dependent degradation of secretory and membrane proteins in semi-permeabilized mammalian cells. Biochem. J. 307: 679-687.
36. Chen, C., and H. Okayama. 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7: 2745-2752.
37. Zhang, Y. 2008. I-TASSER server for protein 3D structure prediction. BMC Bioinformatics 9: 40.
38. Jo, S., T. Kim, and W. Im. 2007. Automated builder and database of protein/membrane complexes for molecular dynamics simulations. PLoS One 2: e880.
39. Kyte, J., and R. F. Doolittle. 1982. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157: 105-132.
40. Borgese, N., S. Colombo, and E. Pedrazzini. 2003. The tale of tail-anchored proteins: coming from the cytosol and looking for a membrane. J. Cell Biol. 161: 1013-1019. (Pubitemid 36870163)
41. Wattenberg, B., and T. Lithgow. 2001. Targeting of C-terminal (tail)-anchored proteins: understanding how cytoplasmic activities are anchored to intracellular membranes. Traffic 2: 66-71. (Pubitemid 32219858)
42. Rabu, C., and S. High. 2007. Membrane protein chaperones: a new twist in the tail? Curr. Biol. 17: R472-R474. (Pubitemid 46899527)
43. Rabu, C., V. Schmid, B. Schwappach, and S. High. 2009. Biogenesis of tailanchored proteins: the beginning for the end? J. Cell Sci. 122: 3605-3612.
44. Rabu, C., P. Wipf, J. L. Brodsky, and S. High. 2008. A precursor-specific role for Hsp40/Hsc70 during tail-anchored protein integration at the endoplasmic reticulum. J. Biol. Chem. 283: 27504-27513.
45. Hessa, T., N. M. Meindl-Beinker, A. Bernsel, H. Kim, Y. Sato, M. Lerch-Bader, I. Nilsson, S. H. White, and G. von Heijne. 2007. Molecular code for transmembrane-helix recognition by the Sec61 translocon. Nature 450: 1026-1030. (Pubitemid 350273612)
46. Stefanovic, S., and R. S. Hegde. 2007. Identification of a targeting factor for posttranslational membrane protein insertion into the ER. Cell 128: 1147-1159.
47. Sullivan, B. M., and L. Coscoy. 2010. The U24 protein from human herpesvirus 6 and 7 affects endocytic recycling. J. Virol. 84: 1265-1275.